End in Mind: Future of Psychedelics in End of Life

Recording: End in Mind: Future of Psychedelics in End of Life, Date TBA

There is compelling evidence that psychedelic substances, when given in a controlled and carefully monitored environment, can reduce existential fear and suffering during serious illness and at end of life. This is a paradigm shift. The fact that a treatment may exist that can reduce trauma and distress for people at a time when modern medicine has no good way of doing so deserves attention. Tune in to hear from practicing clinicians and thought leaders in this rapidly emerging space about how psychedelic therapies are changing the future of end of life care and creating a cultural shift in the way we define the meaning of both living well and ending well.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Andrew Penn

University of California San Francisco

Shoshana Ungerleider, MD

End Well Project

This event will be in person


Primary Entry:
Platinum Badge
Interactive Badge
Secondary Entry:
Music Badge
Film Badge





Health & MedTech track sponsored by Optum


The State of Psychedelics summit sponsored by Vine VC